12/18
08:43 am
tnya
Tenaya Therapeutics (NASDAQ:TNYA) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
Medium
Report
Tenaya Therapeutics (NASDAQ:TNYA) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
12/14
01:35 pm
tnya
Tenaya Therapeutics (TNYA) Is Down 39.7% After Cardiac Gene Therapy Milestones And $60M Fundraise - What's Changed [Yahoo! Finance]
Medium
Report
Tenaya Therapeutics (TNYA) Is Down 39.7% After Cardiac Gene Therapy Milestones And $60M Fundraise - What's Changed [Yahoo! Finance]
12/12
11:24 am
tnya
Tenaya Therapeutics (NASDAQ:TNYA) had its price target lowered by analysts at HC Wainwright from $5.00 to $3.00. They now have a "buy" rating on the stock.
Medium
Report
Tenaya Therapeutics (NASDAQ:TNYA) had its price target lowered by analysts at HC Wainwright from $5.00 to $3.00. They now have a "buy" rating on the stock.
12/12
08:18 am
tnya
Tenaya Therapeutics (NASDAQ:TNYA) had its price target lowered by analysts at Chardan Capital from $9.00 to $8.00. They now have a "buy" rating on the stock.
High
Report
Tenaya Therapeutics (NASDAQ:TNYA) had its price target lowered by analysts at Chardan Capital from $9.00 to $8.00. They now have a "buy" rating on the stock.
12/12
12:16 am
tnya
Tenaya Therapeutics Announces Pricing of Public Offering
High
Report
Tenaya Therapeutics Announces Pricing of Public Offering
12/11
04:47 pm
tnya
Tenaya Therapeutics Announces Rapid Resolution and Lifting of Clinical Hold for MyPEAK-1™ Phase 1b/2a Clinical Trial of TN-201 Gene Therapy [Yahoo! Finance]
High
Report
Tenaya Therapeutics Announces Rapid Resolution and Lifting of Clinical Hold for MyPEAK-1™ Phase 1b/2a Clinical Trial of TN-201 Gene Therapy [Yahoo! Finance]
12/11
04:47 pm
tnya
Tenaya Therapeutics Announces Proposed Public Offering [Yahoo! Finance]
High
Report
Tenaya Therapeutics Announces Proposed Public Offering [Yahoo! Finance]
12/11
04:47 pm
tnya
Tenaya Therapeutics Reports Positive Interim Data from Cohort 1 of RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy for Adults with PKP2-associated ARVC [Yahoo! Finance]
High
Report
Tenaya Therapeutics Reports Positive Interim Data from Cohort 1 of RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy for Adults with PKP2-associated ARVC [Yahoo! Finance]
12/11
04:02 pm
tnya
Tenaya Therapeutics Announces Proposed Public Offering
High
Report
Tenaya Therapeutics Announces Proposed Public Offering
12/11
04:01 pm
tnya
Tenaya Therapeutics Announces Rapid Resolution and Lifting of Clinical Hold for MyPEAK-1™ Phase 1b/2a Clinical Trial of TN-201 Gene Therapy
High
Report
Tenaya Therapeutics Announces Rapid Resolution and Lifting of Clinical Hold for MyPEAK-1™ Phase 1b/2a Clinical Trial of TN-201 Gene Therapy
12/11
04:01 pm
tnya
Tenaya Therapeutics Reports Positive Interim Data from Cohort 1 of RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy for Adults with PKP2-associated ARVC
High
Report
Tenaya Therapeutics Reports Positive Interim Data from Cohort 1 of RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy for Adults with PKP2-associated ARVC
12/4
11:57 pm
tnya
Tenaya Therapeutics: Risky But Promising Cardiac Gene Platform [Seeking Alpha]
Neutral
Report
Tenaya Therapeutics: Risky But Promising Cardiac Gene Platform [Seeking Alpha]
11/10
03:21 pm
tnya
Tenaya Therapeutics (NASDAQ:TNYA) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $9.00 price target on the stock.
Low
Report
Tenaya Therapeutics (NASDAQ:TNYA) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $9.00 price target on the stock.
11/10
03:12 pm
tnya
Tenaya Therapeutics, Inc. (TNYA) Shareholder/Analyst Call Transcript [Seeking Alpha]
Low
Report
Tenaya Therapeutics, Inc. (TNYA) Shareholder/Analyst Call Transcript [Seeking Alpha]
11/10
07:00 am
tnya
Tenaya Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
High
Report
Tenaya Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
11/8
02:14 pm
tnya
Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK™-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy [Yahoo! Finance]
High
Report
Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK™-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy [Yahoo! Finance]
11/8
11:25 am
tnya
Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK™-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy
High
Report
Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK™-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy
11/4
07:01 pm
tnya
Tenaya Therapeutics Announces New Clinical Data for TN-201 Gene Therapy will be Featured in Late-Breaking Presentation at the American Heart Association Scientific Sessions 2025 [Yahoo! Finance]
Low
Report
Tenaya Therapeutics Announces New Clinical Data for TN-201 Gene Therapy will be Featured in Late-Breaking Presentation at the American Heart Association Scientific Sessions 2025 [Yahoo! Finance]
11/4
05:30 pm
tnya
Tenaya Therapeutics Announces New Clinical Data for TN-201 Gene Therapy will be Featured in Late-Breaking Presentation at the American Heart Association Scientific Sessions 2025
Low
Report
Tenaya Therapeutics Announces New Clinical Data for TN-201 Gene Therapy will be Featured in Late-Breaking Presentation at the American Heart Association Scientific Sessions 2025
10/9
04:05 pm
tnya
Tenaya Therapeutics to Participate in H.C. Wainwright Genetic Medicines Virtual Conference
Medium
Report
Tenaya Therapeutics to Participate in H.C. Wainwright Genetic Medicines Virtual Conference
10/9
06:31 am
tnya
Can Tenaya Therapeutics' Leadership Messaging Shape Long-Term Perceptions and Value Creation for TNYA? [Yahoo! Finance]
Medium
Report
Can Tenaya Therapeutics' Leadership Messaging Shape Long-Term Perceptions and Value Creation for TNYA? [Yahoo! Finance]
10/2
05:39 pm
tnya
Tenaya Therapeutics to Participate in Upcoming October Investor Conferences [Yahoo! Finance]
Low
Report
Tenaya Therapeutics to Participate in Upcoming October Investor Conferences [Yahoo! Finance]
10/2
04:05 pm
tnya
Tenaya Therapeutics to Participate in Upcoming October Investor Conferences
Low
Report
Tenaya Therapeutics to Participate in Upcoming October Investor Conferences